© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

France's new €8bn 30 year grabs record demand, performs in secondary

◆ AFT's Antoine Deruennes says 'clear message' showed demand for 30 year ◆ Speedy execution before US employment data ◆ Green OAT syndication next
Deal will bring fourth major multilateral development bank to the market

Fidelidade offers rare Portugese insurance tier two

◆ Refi deal came as issuer prepares IPO ◆ Deal extends the insurer's tier two curve by 10 years ◆ 'Strong bid' for Iberian FIG credit, says rival banker

REN runs into euros with tight EuGB deal

◆ Portuguese utility firm powers up EuGB curve ◆ Sub-benchmark trade's book proves sticky ◆ Deal lands through fair value
Deal will bring fourth major multilateral development bank to the market
Sub-sections
  • India’s Glenmark Life Sciences, a pharmaceutical ingredients maker, has filed draft paperwork for an IPO of new and existing shares.
  • Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.
  • More than 90% of Suriname’s bondholders this week participated in a consent solicitation that extends the sovereign’s debt standstill until the end of July. But the government has only until April 30 to sign a deal with the IMF, or the standstill will be cancelled.